Buy 3 and get 1 for FREE
Buy 5+ for $61.38 and save $23.10
Overview
Science & Research
Safety Information
FAQ
Reviews
Dragon Pharma Oral Product
Dragon Pharma Femara 2.5 mg Overview
Dragon Pharma Femara 2.5 mg is supplied in a sachet containing 100 tablets, each with a labeled strength of 2.5 mg of letrozole. Product specifications, storage information, and available payment options are provided below.
2.5 mg Tablets
Each tablet is labeled to contain 2.5 mg of the active substance letrozole.
100-Tablet Sachet
Supplied as a practical 100-tablet sachet for convenient storage and use.
Aromatase Inhibitor
Letrozole is a non-steroidal aromatase inhibitor that reduces estrogen production.
Dragon Pharma
Manufactured and packaged under the Dragon Pharma product line.
Each product differs in its active substance, strength, or mechanism of action, which can influence its characteristics and use.
Science & Research
Understanding Letrozole
Femara 2.5 mg contains letrozole, a non-steroidal aromatase inhibitor. Unlike steroidal aromatase inhibitors, letrozole reversibly binds to the aromatase enzyme. Its mechanism of action is distinct from that of SERMs.
1
Aromatase Inhibition
Letrozole works by inhibiting the aromatase enzyme, which is responsible for converting androgens such as testosterone into estrogen.
2
Estrogen Reduction
By inhibiting aromatase, letrozole reduces circulating estrogen levels. This differs from the mechanism of SERMs, which block estrogen receptors.
3
Oral Administration
Letrozole is formulated for oral use and is not 17-alpha-methylated, as this modification is not required for its activity.
Medical and Research References
Letrozole has been used in medical contexts, and official resources provide background on its pharmacology and potential effects.
Letrozole is associated with significant side effects. A laboratory report confirms information about the tested sample, but it does not determine whether use is safe or appropriate for an individual.
Bone Health
Reduced estrogen levels can lead to decreased bone mineral density. Individuals with osteoporosis or risk factors for bone loss may be at increased risk.
Cardiovascular Effects
Estrogen reduction can affect lipid profiles and cardiovascular health. Monitoring is advisable for individuals with cardiovascular risk factors.
Hormonal Effects
Aromatase inhibition can affect hormone balance and may impact fertility. Fertility plans should be discussed with a healthcare professional before use.
Mood and Sleep Changes
Reported effects can include mood changes, depression, and insomnia. New, persistent, or severe symptoms should be discussed with a healthcare professional.
Liver Effects
Letrozole is not generally considered hepatotoxic, though monitoring is still advisable.
Drug Interactions
Letrozole can interact with other medications. A healthcare professional should be consulted regarding potential interactions.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with a history of osteoporosis, cardiovascular disease, liver issues, or those taking other medications. The product should be stored securely to prevent accidental access or use by children or other household members.
When to Seek Urgent Medical Help
Seek urgent medical attention for symptoms such as chest pain, signs of a serious allergic reaction, sudden severe headache, or major vision changes.
Tested Sport
Letrozole is a prohibited substance under anti-doping rules in tested sport at all times. The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Dragon Pharma Femara 2.5 mg FAQ
Quick answers about Femara 2.5 mg specifications, storage, shipping, Bitcoin payment, and general product information.
What is Dragon Pharma Femara 2.5 mg?
Dragon Pharma Femara 2.5 mg is an oral tablet product containing letrozole at a labeled strength of 2.5 mg per tablet. It is supplied in a sachet containing 100 tablets. It is a non-steroidal aromatase inhibitor.
How much letrozole is in one sachet?
A 100-tablet sachet labeled at 2.5 mg per tablet provides a total labeled content of 250 mg of letrozole.
How does Femara differ from Arimidex?
Both are non-steroidal aromatase inhibitors, but they have different active substances. Femara contains letrozole, while Arimidex contains anastrozole. They have different pharmacological profiles and are not interchangeable.
How should Femara 2.5 mg be stored?
Follow the storage directions printed on the product label. Keep the product in its original packaging and protect it from excessive heat, moisture, and direct light. Keep it securely out of reach of children and pets.
Does Femara 2.5 mg need refrigeration?
Follow the storage instructions printed on the supplied product. Do not refrigerate or freeze the sachet unless the manufacturer specifically instructs otherwise. Typically, tablets are stored at room temperature.
How long does Femara 2.5 mg delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Femara 2.5 mg with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Femara 2.5 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is letrozole permitted in tested sport?
Letrozole is a prohibited substance under anti-doping rules in tested sport at all times. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find official safety information on letrozole?
Official prescribing and safety information is available from FDA, DailyMed, and MedlinePlus. Direct links to these resources are provided in the Science & Research and Safety sections above.
